Found 3 results
Filters: Author is S.H. Yildiz  [Clear All Filters]
M. O. Erdogan, Yildiz, S. H., Solak, M., Eser, O., Cosar, E., Eser, B., Koken, R., and Buyukbas, S., C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects, vol. 9, pp. 1197-1203, 2010.
Anonymous (1991). Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338: 131-137.   Aydinli K, Cajdas A, Kayserili H, Kuseyri F, et al. (1998). The effect of preconceptional folic acid treatment on the recurrence risk of nonsyndromic neural tube defects. Balk J. Med. Genet. 1: 120-124.   Boduroglu K, Alikasifoglu M, Anar B and Tuncbilek E (1999). Association of the 677C→T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J. Child Neurol. 14: 159-161. PMid:10190266   Christensen B, Arbour L, Tran P, Leclerc D, et al. (1999). Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am. J. Med. Genet. 84: 151-157.<151::AID-AJMG12>3.0.CO;2-T   Cunha AL, Hirata MH, Kim CA, Guerra-Shinohara EM, et al. (2002). Metabolic effects of C677T and A1298C mutations at the MTHFR gene in Brazilian children with neural tube defects. Clin. Chim. Acta 318: 139-143.   Eskes TK (1998). Neural tube defects, vitamins and homocysteine. Eur. J. Pediatr. 157 (Suppl 2): S139-S141. PMid:9587043   Frosst P, Blom HJ, Milos R, Goyette P, et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10: 111-113. PMid:7647779   Goyette P, Pai A, Milos R, Frosst P, et al. (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm. Genome 9: 652-656. PMid:9680386   Karalti MD, Inal M, Yildirim Y, Çoker I, et al. (2007). The relationship between maternal 5,10-methylenetetrahydrofolate reductase C677T polymorphism and the development of neural tube defects: a 5-year study in Aegean Obstetrics and Gynecology Training and Research Hospital. Turkiye Klinikleri J. Gynecol. Obst. 2007: 337-341.   Melvin EC, George TM, Worley G, Franklin A, et al. (2000). Genetic studies in neural tube defects. NTD Collaborative Group. Pediatr. Neurosurg. 32: 1-9. PMid:10765131   Posey DL, Khoury MJ, Mulinare J, Adams MJ Jr, et al. (1996). Is mutated MTHFR a risk factor for neural tube defects? Lancet 347: 686-687.   Samson GR (2003). The incidence and demography of neural tube defects in Abu Dhabi, United Arab Emirates (1992- 1999). J. Trop. Pediatr. 49: 256-257. PMid:12929892   Tunçbilek E, Boduroglu K and Alikasifoglu M (1999). Neural tube defects in Turkey: prevalence, distribution and risk factors. Turk. J. Pediatr. 41: 299-305. PMid:10770089   van der Put NM and Blom HJ (2000). Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur. J. Obstet. Gynecol. Reprod. Biol. 92: 57-61.   van der Put NM, Gabreels F, Stevens EM, Smeitink JA, et al. (1998). A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62: 1044-1051. PMid:9545395 PMCid:1377082   Volcik KA, Blanton SH, Tyerman GH, Jong ST, et al. (2000). Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am. J. Med. Genet. 95: 21-27.<21::AID-AJMG6>3.0.CO;2-M